Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 2Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 47Inflammatory Breast Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Ovarian Neoplasms 2Obesity 2Neoplasm Metastasis 2Central Nervous System Neoplasms 2Breast Carcinoma In Situ 2Breast Cancer Female 2Vitamin D Deficiency 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Sleep Wake Disorders 1Sexuality 1Recurrence 1Pulmonary Fibrosis 1Nutrition Disorders 1Neoplasms 1Melanoma 1Hormone-receptor-positive Breast Cancer 1Gliosarcoma 1Glioblastoma 1Gastrointestinal Neoplasms 1Fallopian Tube Neoplasms 1ER+ Breast Cancer 1Carcinoma, Ovarian Epithelial 1Breast Diseases 1Breast Cancer Patients in Premenopausal 1Breast Cancer Organoids 1Astrocytoma 1

Interventions

pyrotinib 4Letrozole 4Trastuzumab 3Docetaxel 3Anastrozole 3exemestane 2Epirubicin 2Drug Evaluation 2Doxorubicin 2Cyclophosphamide 2Capecitabine 2Aromatase Inhibitors 2palbociclib 1abemaciclib 1Vinorelbine 1Tomography, X-Ray Computed 1Tamoxifen 1Surgimend 1Sodium Chloride 1Paclitaxel 1Mammaplasty 1Liquid Biopsy 1Lead 1Lapatinib 1Goserelin 1Fulvestrant 1Drug Therapy 1Cryotherapy 1Carboplatin 1Botulinum Toxins, Type A 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Breast Diseases × Tamoxifen × Clear all
NCT03373708 2017-12-18

Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer

Shandong Cancer Hospital and Institute

Phase 2/3 Unknown
200 enrolled
Breast

Breast Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡